| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,534 | 6,630 | 11,143 | 16,211 | | Cost of Revenue | 6,652 | 5,155 | 7,881 | 11,071 | | | Gross Profit | 1,882 | 1,475 | 3,262 | 5,140 | | | Operating Expenses | | Research Development | 1,095 | 1,058 | 1,101 | 1,213 | | Selling General and Administrative | 3,773 | 3,837 | 4,469 | 4,473 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,986) | (3,420) | (2,308) | (546) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 46 | (28) | (49) | 115 | | Earnings Before Interest And Taxes | (2,940) | (3,448) | (2,357) | (431) | | Interest Expense | 20 | 18 | 10 |
-
| | Income Before Tax | (2,960) | (3,466) | (2,367) | (431) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,960) | (3,466) | (2,367) | (431) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,960) | (3,466) | (2,367) | (431) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,960) | ($3,466) | ($2,367) | ($431) |
|
0.31% Nasdaq 
0.05%
Income Statement
